Status:
UNKNOWN
ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
40-90 years
Brief Summary
Proteinuria is an expression of diabetic nephropaty in type 1 and type 2 patients. Hypertenshion treatment and decreasing urine protein excretion, slow down renal deterioration. Treating diabetic ,hyp...
Detailed Description
The study group- men and women with diabetes mellitus type 2,who were hospitalized in the department of internal medicine in Assaf- Harofeh Medical Center. During hospitalization, data regarding the ...
Eligibility Criteria
Inclusion
- Type 2 diabetic patients admitted to department of Internal Medicine in Assaf Harofeh Medical Center
Exclusion
- Type 1 diabetes mellitus
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
End Date :
March 1 2007
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00437775
Start Date
January 1 2007
End Date
March 1 2007
Last Update
February 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assaf Harofeh Medical Center
Ẕerifin, Israel, 70300